Evidence map›Paper›PMID 30979808›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury.

Min-Jung Park, Louis G D'Alecy, Michelle A Anderson, Venkatesha Basrur, Yongjia Feng, Graham F Brady, Dong-Il Kim, Jun Wu, Alexey I Nesvizhskii, Joerg Lahann and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Article
  9. Article
  10. Article
  11. Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Min-Jung ParkDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109; gguger1@gmail.com mbishr@umich.edu.
Louis G D'AlecyDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109.
Michelle A AndersonDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Medical School, Ann Arbor, MI 48109.
Venkatesha BasrurDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0002-0853-9655
Yongjia FengDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109.
Graham F BradyDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109.
Dong-Il KimDepartment of Physiology, College of Veterinary Medicine, Chonnam National University, 61186 Gwangju, Republic of Korea.
Jun WuDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109.
Alexey I NesvizhskiiDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Joerg LahannBiointerfaces Institute, College of Engineering, University of Michigan, Ann Arbor, MI 48109.
Nicholas W LukacsDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
Robert J FontanaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Medical School, Ann Arbor, MI 48109.
M Bishr OmaryDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109; gguger1@gmail.com mbishr@umich.edu.
University of Michigan · USÅbo Akademi University · FIChonnam National University · KR

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Keratin Biology and Disease Aspects in Simple EpitheliaR01DK047918 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1995 to 2018
$6.6M
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
NCATS NIH HHS UL1 TR002240NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R01 DK047918NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Carbamoyl phosphate synthetase-1 (CPS1) is the major mitochondrial urea cycle enzyme in hepatocytes. It is released into mouse and human blood during acute liver injury, where is has a short half-life. The function of CPS1 in blood and the reason for its short half-life in serum are unknown. We show that CPS1 is released normally into mouse and human bile, and pathologically into blood during acute liver injury. Other cytoplasmic and mitochondrial urea cycle enzymes are also found in normal mouse bile. Serum, bile, and purified CPS1 manifest sedimentation properties that overlap with extracellular vesicles, due to the propensity of CPS1 to aggregate despite being released primarily as a soluble protein. During liver injury, CPS1 in blood is rapidly sequestered by monocytes, leading to monocyte M2-polarization and homing to the liver independent of its enzyme activity. Recombinant CPS1 (rCPS1), but not control r-transferrin, increases hepatic macrophage numbers and phagocytic activity. Notably, rCPS1 does not activate hepatic macrophages directly; rather, it activates bone marrow and circulating monocytes that then home to the liver. rCPS1 administration prevents mouse liver damage induced by Fas ligand or acetaminophen, but this protection is absent in macrophage-deficient mice. Moreover, rCPS1 protects from acetaminophen-induced liver injury even when given therapeutically after injury induction. In summary, CPS1 is normally found in bile but is released by hepatocytes into blood upon liver damage. We demonstrate a nonenzymatic function of CPS1 as an antiinflammatory protective cytokine during acute liver injury.

Indexed as

AcetaminophenAcute Lung InjuryAdultAnimalsBileBile Acids and SaltsCarbamoyl-Phosphate Synthase (Ammonia)CytokinesFas Ligand ProteinFemaleHepatocytesHumansLiverLiver DiseasesMacrophagesMaleAcetaminophenBile Acids and SaltsCarbamoyl-Phosphate Synthase (Ammonia)CPS1 protein, humanCytokinesFas Ligand Proteinacetaminophenbile proteomeFas ligandmacrophage polarizationmitochondria

Identifiers

PMID30979808
PMCPMC6500125
OpenAlexW2937232990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.